drugset / Trial / NCT04050293
Therapy for Migraine Prevention in Children 6-11 Years of Age
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of this study is to evaluate the effect of SPN-538 for the prophylaxis of migraine in pediatric patients 6 to 11 years old.
Timeline
- Start
- 2020-07-14
- Primary completion
- 2023-03-01
- Completion
- 2023-03-01
Outcome
Outcome not reported
Stopped (Enrollment): “Difficulty in recruitment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SPN-538 | Unknown | 2 mg/kg | Oral |
| Subject | SPN-538 | Unknown | 3 mg/kg | Oral |